Texas-based Barnett Shale driller prices below the estimated range, while obesity-drug developer BioAge prices midrange ahead ...

Obesity-drug developer BioAge Labs Inc. gained nearly 30% after its initial public offering on Thursday, while natural-gas producer BKV Inc.'s rose about 3% over its $18 IPO price. BioAge (BIOA) stock ...

Texas-based Barnett Shale driller BKV Inc. priced below the estimated range, while obesity-drug developer BioAge Labs Inc. priced midrange ahead of their first day of trading on Thursday. As the ...

BKV Corp. has positioned itself as an LNG supplier near Gulf Coast markets with production averaging 718 MMcfe/d across about ...

BKV Corp. priced its common shares at $18 each after and will begin trading on Sept. 26, about two years after the Denver ...

Texas-based Barnett Shale driller prices below the estimated range, while obesity-drug developer BioAge prices midrange ahead ...

It is pleasant, to be sure, a friendly, bucolic town of about 3,300 residents nestled in its gently rolling hills. Shane […] ...

The West Texas Geological Society’s fall symposium featured a comprehensive 'Permian 101' lesson on the history and ...

Natural gas producer BKV Corp said on Wednesday it had raised $270 million in its U.S. initial public offering.

As the editor of The Prudent Speculator newsletter, I firmly believe in "eating my own cooking" when it comes to investing.